Join
Live feed
·
PRReleasevia Quantisnow
Eli Lilly and Company logo
Ventyx Biosciences Inc. logo

Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LLY (Eli Lilly and Company), VTYX (Ventyx Biosciences Inc.) and more on Quantisnow.